At the TMS Institute of Arizona, we offer a range of advanced neuromodulation therapies tailored to individual patient needs. All treatments are personalized based on clinical evaluation and the latest research, and are prescribed by medical experts at our clinic in Scottsdale, Arizona.
FDA-Approved Treatments
The following conditions are approved by the FDA for treatment with one or more of our advanced therapies, including TMS (Transcranial Magnetic Stimulation):
| Condition | Treatment | FDA Approval Status |
|---|---|---|
| Major Depressive Disorder (MDD) | TMS | FDA-approved |
| Treatment-Resistant Depression (TRD) | TMS | FDA-approved |
| Obsessive-Compulsive Disorder | TMS | FDA-approved |
| Smoking Cessation | TMS | FDA-approved |
| Chronic Pain | TMS via peripheral nerve stimulation* | FDA-approved |
*TMS Institute of Arizona is the only medical office in Arizona that offers this treatment.
Off-Label and Emerging Uses of Neuromodulation
Beyond FDA-approved indications, neuromodulation therapies like MeRT, tDCS, and Accelerated TMS are frequently and safely used by clinicians to address a variety of neurological and mental health conditions. These evidence-informed applications are an established part of personalized care, offering additional options when standard treatments may not fully meet patient needs.
| Condition | Potential Therapy | Notes |
|---|---|---|
| Anxiety | TMS, MeRT, tDCS | Not FDA-approved, but growing evidence supports effectiveness |
| Autism Spectrum Disorder (ASD) | TMS, MeRT | Shows promise in improving communication, emotional regulation, attention and focus, and social skills. |
| ADHD | TMS, tDCS, MeRT | May improve attention and executive function. |
| Post-Concussion Syndrome/TBI | TMS, MeRT, tDCS | Targets brainwave imbalances and lingering cognitive symptoms |
| Cognitive Decline and Dementia | TMS, tDCS | Used to enhance memory and mental clarity |
| Sleep Disorders | TMS, MeRT | May help regulate sleep-wake cycles and reduce insomnia |
| Chronic Fatigue Syndrome (CFS) | TMS | Early-stage research shows potential for symptom relief |
| Chronic Pain & Headaches | tDCS, TMS | May help manage fibromyalgia, migraines, and tension headaches |
| Tinnitus | TMS | Some studies suggest symptom reduction with stimulation |
| Parkinson’s Disease & Tremors | TMS, tDCS | Used as adjunctive therapy for motor symptoms |
| Eating Disorders | TMS, tDCS | Investigated for impulse control and mood regulation |
| Weight Management | TMS, tDCS | May help reduce cravings and support behavioral change |
| Stroke Recovery | TMS | May aid in neuroplasticity and motor recovery |
Note: These uses are considered off-label and not yet FDA-approved. Treatments are offered only after a clinical evaluation and on a case-by-case basis.
Why Choose TMS Institute of Arizona?
